Latest M/I Homes (MHO) Headlines Fitch Affirms M/I

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest M/I Homes (MHO) Headlines

Fitch Affirms M/I Homes' IDR at 'B'; Outlook Stable
Business Wire - Wed Mar 05, 9:23AM CST
Fitch Ratings has affirmed the ratings for M/I Homes, Inc. (NYSE: MHO), including the company's Issuer Default Rating (IDR) at 'B'. The Rating Outlook is Stable.

Housing-Related Stocks Hold Up Despite Weak Data
at The Street - Mon Feb 24, 10:07AM CST
We're crunching the numbers for the 19 housing sector index components and the recent data for homebuilder sentiment and single-family housing starts.

M/I Homes Announces Quarterly Cash Dividend on Preferred Shares
PR Newswire - Tue Feb 18, 3:25PM CST
M/I Homes, Inc. (NYSE: MHO) announced today that its Board of Directors has declared a cash dividend of $0.609375 per share on its outstanding depositary shares (NYSE: MHO-PrA), each representing 1/1,000th of a Series A Preferred Share of M/I Homes (the "Depositary Shares"), for the first quarter of 2014. The dividend is payable on March 17, 2014 to holders of record of the Depositary Shares on March 1, 2014.

Uptrend Call Working As M/I Homes Stock Rises 14.5% (MHO)
Comtex SmarTrend(R) - Fri Feb 07, 9:20AM CST
SmarTrend identified an Uptrend for M/I Homes (NYSE:MHO) on October 24th, 2013 at $21.16. In approximately 4 months, M/I Homes has returned 14.51% as of today's recent price of $24.23.

The Housing Recovery Continues
Daniel James, The Motley Fool - Motley Fool - Wed Feb 05, 10:02AM CST
Following the spectacular growth recorded by homebuilders during the heights of the housing recovery, figures indicating  slowdown may lead one to think that the recovery is over. Indeed, some commentators have claimed that this is the case. However,...

Trading 12 Homebuilders With Mixed Earnings and Housing Data
at The Street - Mon Feb 03, 8:51AM CST
Homebuilders are vulnerable once again as sentiment slips in January with weaker-than-expected single-family housing starts in December.

Homebuilders' Earnings Bear Watching
at The Street - Sat Feb 01, 9:00AM CST
Long-term fundamentals look favorable, but we shouldn't overlook near-term concerns.

9 States With the Highest Unemployment Rates
Sean Williams, The Motley Fool - Motley Fool - Fri Jan 31, 2:06PM CST
I've always been amazed by how quickly a recession can shoot the unemployment rate higher and, conversely, how long it can take for the jobs market to stabilize and for corporations to begin hiring following a recession. The recession we witnessed...

Homebuilder Earnings Remain Strong, But Shares Pause
at Investor's Business Daily - Thu Jan 30, 10:04AM CST
Three more homebuilders beat earnings views Thursday, but shares were mixed after a separate report showed an unexpected plunge in pending home sales. Pulte Group (PHM), Ryland Group (RYL) and Beazer Homes USA (BZH) all reported better-than-expected...

M/I Homes Q4 Earnings Jump But Still Miss Forecasts
at Investor's Business Daily - Wed Jan 29, 10:43AM CST
M/I Homes' (MHO) fourth-quarter earnings shot up as deliveries and market share improved, but profit still fell short of Wall Street estimates. The homebuilder said it earned 48 cents a share for the quarter, up from 23 cents a share a year earlier....

M/I Homes Reports Fourth Quarter and Year-End Results
PR Newswire - Wed Jan 29, 7:30AM CST
M/I Homes, Inc. (NYSE:MHO) announced results for its fourth quarter and year ended December 31, 2013.

M/I Homes, Inc. Announces Fourth Quarter and Year-End Earnings Webcast
PR Newswire - Wed Jan 29, 6:45AM CST
M/I Homes, Inc. (NYSE: MHO) announces the following Webcast:

Builders Rise On D.R. Horton Earnings, Home Prices
at Investor's Business Daily - Tue Jan 28, 11:52AM CST
Homebuilders rose sharply in afternoon trading on the stock market today after D.R. Horton (DHI) topped quarterly estimates and home prices continued to show strong year-over-year growth. D.R. Horton logged earnings of 36 cents a share for its fiscal...

Homebuilders Eye More Gains, Though Challenges Loom
at Investor's Business Daily - Sat Jan 25, 7:02AM CST
Homebuilders due to report earnings this week should see strong gains for at least another quarter. After that, the picture gets muddled by rising home prices and mortgage rates. Pulte Group (PHM), D.R. Horton (DHI), M/I Homes (MHO), Ryland Group...

M/I Homes Up 21.5% Since SmarTrend Uptrend Call (MHO)
Comtex SmarTrend(R) - Thu Jan 23, 11:07AM CST
SmarTrend identified an Uptrend for M/I Homes (NYSE:MHO) on October 24th, 2013 at $21.16. In approximately 3 months, M/I Homes has returned 21.50% as of today's recent price of $25.71.

M/I Homes Has Returned 20.2% Since SmarTrend Recommendation (MHO)
Comtex SmarTrend(R) - Thu Jan 09, 9:13AM CST
SmarTrend identified an Uptrend for M/I Homes (NYSE:MHO) on October 24th, 2013 at $21.16. In approximately 3 months, M/I Homes has returned 20.18% as of today's recent price of $25.43.

M/I Homes Shares Up 20.4% Since SmarTrend's Buy Recommendation (MHO)
Comtex SmarTrend(R) - Tue Dec 31, 10:03AM CST
SmarTrend identified an Uptrend for M/I Homes (NYSE:MHO) on October 24th, 2013 at $21.16. In approximately 2 months, M/I Homes has returned 20.37% as of today's recent price of $25.47.

M/I Homes (MHO) Stock Research Links

MHO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading